![](/img/cover-not-exists.png)
P690 Comparative efficacy of vedolizumab and adalimumab as second-line therapy in ulcerative colitis patients previously treated with infliximab
Favale, A, Onali, S, Caprioli, F, Pugliese, D, Armuzzi, A, Macaluso, F S, Orlando, A, Viola, A, Fries, W, Mocci, G, Chicco, F, Usai, P, Rispo, A, Castiglione, F, Calabrese, E, Biancone, L, Monteleone,Volume:
13
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjy222.814
Date:
January, 2019
File:
PDF, 92 KB
2019